CLPT
Price:
$11.835
Market Cap:
$326.46M
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blac...[Read more]
Industry
Medical - Devices
IPO Date
2012-05-22
Stock Exchange
NASDAQ
Ticker
CLPT
According to ClearPoint Neuro, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.54. This represents a change of 18.60% compared to the average of 3.83 of the last 4 quarters.
The mean historical Current Ratio of ClearPoint Neuro, Inc. over the last ten years is 4.76. The current 4.54 Current Ratio has changed 9.45% with respect to the historical average. Over the past ten years (40 quarters), CLPT's Current Ratio was at its highest in in the March 2021 quarter at 22.55. The Current Ratio was at its lowest in in the September 2015 quarter at 0.60.
Average
4.76
Median
3.11
Minimum
1.11
Maximum
13.02
Discovering the peaks and valleys of ClearPoint Neuro, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 304.37%
Maximum Annual Current Ratio = 13.02
Minimum Annual Increase = -53.16%
Minimum Annual Current Ratio = 1.11
Year | Current Ratio | Change |
---|---|---|
2023 | 4.87 | -35.43% |
2022 | 7.54 | -42.10% |
2021 | 13.02 | 65.44% |
2020 | 7.87 | 205.55% |
2019 | 2.58 | -22.29% |
2018 | 3.31 | 14.37% |
2017 | 2.90 | 43.72% |
2016 | 2.02 | 80.88% |
2015 | 1.11 | -53.16% |
2014 | 2.38 | 304.37% |
The current Current Ratio of ClearPoint Neuro, Inc. (CLPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.48
5-year avg
7.18
10-year avg
4.76
ClearPoint Neuro, Inc.’s Current Ratio is greater than Telesis Bio, Inc. (1.89), less than AVITA Medical, Inc. (6.25), less than Sight Sciences, Inc. (10.18), greater than Treace Medical Concepts, Inc. (4.12), less than NeuroPace, Inc. (5.59), greater than Inogen, Inc. (2.66), greater than Surmodics, Inc. (3.96), less than Pulmonx Corporation (7.70), less than Apyx Medical Corporation (5.46), greater than ProSomnus, Inc. Common Stock (0.30), greater than LivaNova PLC (3.37), less than Electromed, Inc. (5.53), less than OrthoPediatrics Corp. (7.17), less than ShockWave Medical, Inc. (13.81), greater than Inari Medical, Inc. (1.77), less than Outset Medical, Inc. (6.49), less than Inspire Medical Systems, Inc. (7.84), less than Cytosorbents Corporation (1.97K), greater than TELA Bio, Inc. (2.62),
Company | Current Ratio | Market cap |
---|---|---|
1.89 | $1.62M | |
6.25 | $349.74M | |
10.18 | $203.53M | |
4.12 | $487.79M | |
5.59 | $289.53M | |
2.66 | $223.42M | |
3.96 | $561.12M | |
7.70 | $268.12M | |
5.46 | $54.40M | |
0.30 | $8.18M | |
3.37 | $2.79B | |
5.53 | $251.96M | |
7.17 | $637.85M | |
13.81 | $12.57B | |
1.77 | $2.91B | |
6.49 | $44.01M | |
7.84 | $5.66B | |
1.97K | $50.31M | |
2.62 | $118.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ClearPoint Neuro, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ClearPoint Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is ClearPoint Neuro, Inc.'s Current Ratio?
How is the Current Ratio calculated for ClearPoint Neuro, Inc. (CLPT)?
What is the highest Current Ratio for ClearPoint Neuro, Inc. (CLPT)?
What is the 3-year average Current Ratio for ClearPoint Neuro, Inc. (CLPT)?
What is the 5-year average Current Ratio for ClearPoint Neuro, Inc. (CLPT)?
How does the current Current Ratio for ClearPoint Neuro, Inc. (CLPT) compare to its historical average?